Blocking function of allergen-specific immunoglobulin G, F(ab')


Journal

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
ISSN: 1534-4436
Titre abrégé: Ann Allergy Asthma Immunol
Pays: United States
ID NLM: 9503580

Informations de publication

Date de publication:
06 2022
Historique:
received: 13 01 2022
revised: 10 03 2022
accepted: 16 03 2022
pubmed: 12 4 2022
medline: 31 5 2022
entrez: 11 4 2022
Statut: ppublish

Résumé

The blocking function of allergen-specific F(ab') To investigate the inhibitory function of sIgG, sF(ab') This study involved 10 subjects (aged 18-42 years) with house dust mite allergic rhinitis or asthma who received a 156-week course of Der-p SCIT. Total IgG levels were purified from the serum of the participants at weeks 0 and 156 by protein A affinity chromatography. Der-p sIgG was purified by affinity chromatography with Der-p as a ligand at week 156. The sF(ab') We found that the Der-p sIgG, sF(ab') SCIT-induced Der-p sIgG, sF(ab') This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University and registered in the Chinese Clinical Trial Registry (ChiCTR-OOC-15006207, https://www.chictr.org.cn/enindex.aspx).

Sections du résumé

BACKGROUND
The blocking function of allergen-specific F(ab')
OBJECTIVE
To investigate the inhibitory function of sIgG, sF(ab')
METHODS
This study involved 10 subjects (aged 18-42 years) with house dust mite allergic rhinitis or asthma who received a 156-week course of Der-p SCIT. Total IgG levels were purified from the serum of the participants at weeks 0 and 156 by protein A affinity chromatography. Der-p sIgG was purified by affinity chromatography with Der-p as a ligand at week 156. The sF(ab')
RESULTS
We found that the Der-p sIgG, sF(ab')
CONCLUSION
SCIT-induced Der-p sIgG, sF(ab')
CLINICAL TRIAL REGISTRATION
This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University and registered in the Chinese Clinical Trial Registry (ChiCTR-OOC-15006207, https://www.chictr.org.cn/enindex.aspx).

Identifiants

pubmed: 35405358
pii: S1081-1206(22)00293-9
doi: 10.1016/j.anai.2022.03.031
pii:
doi:

Substances chimiques

Allergens 0
Antigens, Dermatophagoides 0
Arthropod Proteins 0
Immunoglobulin G 0
Immunologic Factors 0
Immunoglobulin E 37341-29-0

Banques de données

ChiCTR
['ChiCTR-OOC-15006207']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

689-696

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Huan Zhang (H)

Huizhou Central People's Hospital, Huizhou, Guangdong, People's Republic of China.

Mo Xian (M)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.

Xu Shi (X)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.

Tian Luo (T)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.

Qiujuan Su (Q)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.

Jing Li (J)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China. Electronic address: lijing@gird.cn.

Mulin Feng (M)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China; People's Hospital of Yangjiang, Yangjiang, Guangdong, People's Republic of China. Electronic address: pinsium@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH